Headlines & Global News

FDA approves Celgene's Otezla for psioratic arthritis
Treatment for PSA, which affects about 30% of the 125 million people worldwide who have psoriasis, currently involves corticosteroids, disease-modifying antirheumatic drugs (DMARDs) and injectable tumour necrosis factor (TNF) inhibitors, notably AbbVie ...
Celgene's Otezla is first oral therapy OKed by FDA for adults with active ...The Pharma Letter
FDA Approves Otezla, New Medication For Psoriatic ArthritisThe Almagest
FDA approves Celgene drug for psoriatic arthritisYahoo News
all 54 news articles »